Post Profile






Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

(University at Buffalo) A majority of patients with type 1 diabetes who were treated with dapagliflozin, a type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes and Endocrinology.
read more

share

Related Posts


Study advances efforts to screen all children for Type 1 diabetes

Health : EurekAlert: Health

(Johns Hopkins Medicine) Researchers from the Johns Hopkins University School of Medicine, Stanford University and the University of Florida report the development of a novel antibody detection technology that holds promise for impr...

Is the Finger-Stick Blood Test Necessary for Type 2 Diabetes Treatment?

Health : Newswise Medical News

In a landmark study, UNC School of Medicine researchers have shown that blood glucose testing does not offer a significant advantage in blood sugar control or quality of life for type 2 diabetes patients who are not treated with ins...

JANUVIA (sitagliptin) Significantly Reduced Blood Sugar Levels, Was Not Associated With Hypoglycemia In Elderly Patients With Type 2 Diabetes: Study

Health : Medical News Today

New data presented at the 61st Annual Scientific Meeting of the Gerontological Society of America showed JANUVIA™ (sitagliptin), a diabetes medicine from Merck & Co., Inc., significantly reduced blood sugar levels in elderly patient...

New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes

Academics / General Science : Science Codex

A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes. Principal results were published today in the New England Journal of...

New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes

Health : EurekAlert: Health

(University of Colorado Anschutz Medical Campus) A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes. Principal results w...

Comments


Copyright © 2016 Regator, LLC